Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Products & comparisons
Product source

DSLD label record: SuperSmart Nicotinamide Mononucleotide 125 mg capsules

This DSLD record lists a SuperSmart capsule product declaring 125 mg nicotinamide mononucleotide per labelled serving; it is a label declaration, not evidence of efficacy, safety or approval. [1]

Automatic summary · not editorially reviewed

Label · NIH DSLD
Nicotinamide Mononucleotide 125 mgOriginal label · NIH DSLD
Nicotinamide Mononucleotide 125 mg

FROM THE ORIGINAL LABEL

A closer look at the product

Pack contents
30 Vegetarian Capsule(s)
Label serving
1 Vegetarian Capsule(s)
Servings per container
30
Barcode / SKU
5 453003 826743
Open original label (PDF)
Ingredients & declared amounts1

Amounts from the label, per specified serving. These are manufacturer declarations, not a personal dosage recommendation.

IngredientAmountPer label serving
Nicotinamide Mononucleotide125 mg1 Vegetarian Capsule(s)

Other ingredients: Acacia Gum

Source: National Institutes of Health, Office of Dietary Supplements · Dietary Supplement Label Database. Label snapshot; packaging and formulation may have changed.

The key findings

  1. DSLD record 285371 lists the product Nicotinamide Mononucleotide 125 mg with SuperSmart as the declared brand and capsule as the label form. [1]

  2. The record declares 125 mg nicotinamide mononucleotide per labelled serving as a label fact, not dosing advice. [1]

  3. DSLD inclusion does not establish efficacy, safety, FDA approval, laboratory verification or current retail availability. [1]

The source at a glance

Brand
SuperSmart
Form
Capsule
Pack contents
30 Vegetarian Capsule(s)
Label serving
1 Vegetarian Capsule(s)
Ingredients listed
Nicotinamide Mononucleotide
Record type / format
Dietary supplement label/database record (DSLD), not a study.
Scope / context
The described product: SuperSmart Nicotinamide Mononucleotide 125 mg capsules, not a patient population.
Summary based on
Product label / database record

SuperSmart NMN capsule in the DSLD record

The NIH Dietary Supplement Label Database lists record 285371 under the product label name Nicotinamide Mononucleotide 125 mg, with SuperSmart given as the declared brand. The label form is a capsule, and the database category is Non-Nutrient/Non-Botanical. The record notes that the label entered DSLD on 2023-11-22, which is not a product launch date.

Supporting source [1]

Declared ingredient: 125 mg NMN per serving

The only declared ingredient with an amount in this record is nicotinamide mononucleotide, at 125 mg per labelled serving. This is a label fact, not personal dosing advice, and the record supplies no independent product testing, price or batch certificate.

Supporting source [1]

What DSLD inclusion does not establish

The record states that inclusion in DSLD does not establish efficacy, safety, FDA approval, laboratory verification or current retail availability. It describes label declarations only, so it cannot show that the product works or is approved.

Supporting source [1]

How to interpret this

Product label record; not evidence of efficacy or approval. The record describes label declarations only and supplies no independent testing, price or batch certificate.

Based on a product label or database record. This does not establish effectiveness, independent batch testing, approval or current availability.

Source & supporting passages

[1]
Nicotinamide Mononucleotide 125 mg

SuperSmart · dsld.od.nih.gov

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    Brand as declared: SuperSmart
  2. Finding 2 ↑

    Nicotinamide Mononucleotide: 125 mg per labelled serving
  3. Finding 3 ↑

    DSLD inclusion does not establish efficacy, safety,

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

KEEP EXPLORING

Search more

Connected through ingredients, topics and content. A related study does not establish the effectiveness of this specific product.

Products

NMN 300 mg powder: DSLD label record for California Gold Nutrition

The DSLD record lists a California Gold Nutrition powder labelled NMN 300 mg, with Beta-Nicotinamide Mononucleotide 300 mg per labelled serving. It is a label declaration only, not evidence of efficacy, safety or approval.

Related ingredient
Videos

Video description on NMN, NAD and claimed anti-aging benefits

The description says the video explains what nicotinamide mononucleotide does in the body, how it supports NAD levels, and what clinical research reportedly shows about safety, anti-aging benefits and physical performance. No results are given in the description itself.

Related ingredient
Research

Fetal hypoxia in mice reduced oocyte quality and litter size; NMN partly restored pup numbers

In a mouse model kept in a high-plateau hypoxic setting from embryonic day 0 to 16.5, fetal hypoxia was linked to fewer pups per litter, oocyte mitochondrial dysfunction, oxidative stress and Sirt3/Sod2 downregulation; nicotinamide mononucleotide (NMN) administration was reported to alleviate these oocyte impairments.

Related ingredient
Discussions

Was müsste euch bei NAD⁺ und NMN wirklich überzeugen?

Bei NAD⁺ und NMN stoße ich immer wieder auf große Erwartungen. Mich interessiert, nach welchen Kriterien ihr die Informationen dazu bewertet. Reicht euch eine plausible Erklärung des Mechanismus oder wollt ihr Ergebnisse aus kontrollierten

Related ingredient
Topics

NAD⁺ & NMN

What a small human NMN study measured, and why the result cannot speak for every supplement.

Related ingredient
Regulation

FDA Rule Record: Higher Vitamin D3 in Fermented Cultured Dairy Products

An FDA rule record says the agency is amending food additive regulations to allow safe use of vitamin D3 as a nutrient supplement in yogurt and other cultured dairy products fermented with the named bacteria, at a level higher than currently permitted, following a petition by General Mills.

Same topic
Articles

Rhonda Patrick

Interviews and science discussions. Presenter interpretation and commercial relationships need to be considered separately from study results.

Same topic
Products

GO2 Max capsule label record in the NIH DSLD (record 303439)

The NIH Dietary Supplement Label Database lists GO2 Max, a capsule from the brand HTLT, with declared label amounts for two B vitamins, sodium, nicotinamide mononucleotide, ElevATP and black pepper fruit extract. The record is a label declaration, not evidence of efficacy or approval.

Related ingredient
Videos

Video description: NAD⁺ decline, lifestyle boosters and supplement questions

The description says NAD⁺ declines naturally and links this to metabolic stress, DNA damage and mitochondrial dysfunction as precursors of age-related conditions. It says exercise and fasting are proven to boost NAD⁺ levels and asks whether supplements such as nicotinamide riboside and nicotinamide mononucleotide are a viable path.

Related ingredient
Research

NMN plus glucose in mice under hypobaric hypoxia: tissue injury and iron overload

In mice under hypobaric hypoxia, a combined regimen of nicotinamide mononucleotide (NMN) and glucose reduced tissue injury and body weight loss and counteracted metabolic disruptions; the abstract links these effects to iron overload, oxidative stress and ferroptosis-related metabolic changes.

Related ingredient
Discussions

Was ist euer unkompliziertes Essen für stressige Tage?

Über gesunde Ernährung zu lesen ist das eine. An einem vollen Arbeitstag etwas Vernünftiges auf den Tisch zu bringen, ist manchmal die größere Aufgabe. Welche einfachen Gerichte funktionieren bei euch, wenn wenig Zeit und Lust zum Kochen bl

Same topic
Topics

Nutrition foundations

Explore the difference between a dietary pattern, an isolated ingredient and a longevity claim.

Same topic

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…